Citius Pharmaceuticals, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CTXR research report →
Companywww.citiuspharma.com
Citius Pharmaceuticals, Inc. , a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected catheter; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that intends to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome; and I/ONTAK, an engineered IL-2 diphtheria toxin fusion protein for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma.
- CEO
- Leonard L. Mazur
- IPO
- 2014
- Employees
- 23
- HQ
- Cranford, NJ, US
Price Chart
Valuation
- Market Cap
- $6.41M
- P/E
- -0.24
- P/S
- 1.14
- P/B
- 0.21
- EV/EBITDA
- -0.05
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 37.36%
- Op Margin
- -1041.44%
- Net Margin
- -945.92%
- ROE
- -77.46%
- ROIC
- -75.21%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-37,433,911 · 4.36%
- EPS
- $-3.38 · 43.38%
- Op Income
- $-38,525,608
- FCF YoY
- 5.85%
Performance & Tape
- 52W High
- $2.48
- 52W Low
- $0.48
- 50D MA
- $0.77
- 200D MA
- $1.03
- Beta
- 1.05
- Avg Volume
- 790.45K
Get TickerSpark's AI analysis on CTXR
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 8, 25 | Mazur Leonard L | other | 125,490 |
| Aug 8, 25 | Mazur Leonard L | other | 89,388 |
| Aug 8, 25 | Mazur Leonard L | sell | 125,490 |
| Aug 8, 25 | Mazur Leonard L | sell | 89,388 |
| Aug 8, 25 | HOLUBIAK MYRON Z | other | 31,373 |
| Aug 8, 25 | HOLUBIAK MYRON Z | other | 22,344 |
| Aug 8, 25 | HOLUBIAK MYRON Z | sell | 22,344 |
| Aug 8, 25 | HOLUBIAK MYRON Z | sell | 31,373 |
| Nov 7, 24 | Webb Carol | other | 125,000 |
| Nov 7, 24 | Smith Robert Joseph | other | 125,000 |
Our CTXR Coverage
We haven't published any research on CTXR yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CTXR Report →